NCT02965703View on ClinicalTrials.gov

Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

January 31, 2023

Study Completion Date

December 13, 2025

Conditions
Colorectal AdenomaColorectal Carcinoma
Interventions
DRUG

Aspirin

Given PO

PROCEDURE

Biospecimen Collection

Undergo collection of blood, urine, stool, and rectal swab samples

OTHER

Placebo Administration

Given PO

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Rectal Biopsy

Undergo rectal biopsy

Trial Locations (1)

37232

Vanderbilt University/Ingram Cancer Center, Nashville

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH